Isoxazoline compounds as antiinflammatory agents
US5716967A · kind A · utility
40Cited by
5References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 15, 1996 |
| Grant date | Feb 10, 1998 |
| Priority date | — |
| Expiry date | May 15, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to isoxazoline compounds which are selective inhibitors of phosphodiesterase type IV (PDE.sub.IV). The isoxazoline compounds are useful in inhibiting PDE.sub.IV and in the treatment of AIDS, asthma, arthritis, bronchitis, chronic obstructive pulmonary disease, psoriasis, allergic rhinitis, dermatitis, shock, atopic dermatitis, rheumatoid arthritis and osteoarthritis. This invention also relates to pharmaceutical compositions useful therefor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.